Anti-SARS-CoV-2 RBD Antibody

Supplier: GenScript Biotech
GenScript®
A02087-100
76510-196EA 3705.07 CAD
76510-196
Anti-SARS-CoV-2 RBD Antibody
Antibodies
The product is specific for SARS-CoV-2 RBD domain.The product can neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Gamma, Delta, but can't neutralize Omicron BA.1, Omicron BA.2 and Omicron BA.4/BA.5.

  • COVID-19 antibodies
  • Validated for ELISA, WB, FACS, and SARS-CoV-2 virus neutralization assay
  • Control antibodies and various antibody pairs available for ELISA-based detection
  • Neutralizing Antibody Standard to calibrate quantitative assay of SARS-CoV-2 neutralizing antibodies in samples

Genscript offers site-specific Neutralizing antibodies, neutralizing antibody standards, and control antibodies.

Type: Primary
Antigen: SARS-CoV-2 RBD
Clonality:
Clone:
Conjugation:
Epitope:
Host:
Isotype: IgG
Reactivity:
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR